Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Leveraging Local Indigenous Community Voices to Inform Pediatric Healthcare: A Workshop Summary.
Journal: The Journal of pediatrics
Published: April 24, 2026
A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 28, 2025
Towards the implementation of Indigenous data governance in neurogenomics research.
Journal: Nature neuroscience
Published: September 30, 2025
AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors.
Journal: NPJ precision oncology
Published: August 19, 2025
PNOC009: Convection-enhanced delivery of liposomal irinotecan in patients with newly diagnosed diffuse intrinsic pontine glioma.
Journal: Neuro-oncology advances
Published: June 27, 2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Journal: Nature medicine
Published: April 16, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhood.
Journal: Neuro-oncology
Published: April 05, 2025
Assessing Cognitive Functioning in Children With Brain Tumors: Interaction of Neighborhood Social Determinants of Health and Neurological Risk.
Journal: Pediatric blood & cancer
Published: February 10, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Journal: Cancer discovery
Published: January 30, 2025
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the Pediatric Brain Tumor Atlas and Pediatric Neuro-Oncology Consortium.
Journal: Neuro-oncology
Published: January 23, 2025
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial.
Journal: Neuro-oncology
Published: December 19, 2024
Last Updated: 09/26/2026